Security key
67080T108
- Security type / class
- Equity / COM
- Total 13F shares
- 473,417
- Total 13F value
- $8,721,234
- Share change
- -5,065
- SEC-reported price per share
- $18.39
- Number of holders
- 11
- Value change
- +$48,633
- Number of buys
- 8
- Number of sells
- 3
Report period
Q2 2026
Institutions
11
Top holders
10
NVCT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Nuvectis Pharma, Inc. SEC filings
Nuvectis Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080T108
Recent filing periods:
Ownership snapshot
Top reported holders of NVCT - Nuvectis Pharma, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ron Bentsur
Disclosed value leader
Ron Bentsur
Comparable rows
0/15
Latest evidence
30 Jun 2026
3/4/5
13F
Highest disclosed value: $73,768,480
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ron Bentsur has the largest disclosed position value at $73.77M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ron Bentsur's linked filing trail.
Disclosed position value
Top 5
Ron Bentsur
$73.77M
Marlio Charles Mosseri
$59.22M
Enrique Poradosu
$13.64M
Shay Shemesh
$13.54M
BlackRock, Inc.
$5.91M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ron Bentsur |
3/4/5
Chairman & CEO, Director, 10%+ Owner
|
—
class O/S missing
|
$73,768,480
3,688,424 shares
|
+$278,600 | 30 Jun 2026 |
| Marlio Charles Mosseri |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$59,223,123
3,295,897 shares
|
+$1,873,083 | 30 Jun 2026 |
| Enrique Poradosu |
3/4/5
Chief Science & Business Off
|
—
class O/S missing
|
$13,637,527
1,806,319 shares
|
— | 06 Jan 2026 |
| Shay Shemesh |
3/4/5
Chief Dev. & Ops. Officer
|
—
class O/S missing
|
$13,537,484
1,793,068 shares
|
— | 06 Jan 2026 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$5,909,128
764,441 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$5,100,865
659,879 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
473,417
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
62
Q2 2026 holders
11
Holder diff
-51
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend